Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

FOLD.US Logo

FOLD.US - Current Price

$14.28

Company Information

▼
Company Name
Amicus Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US03152W1099
CIK: 0001178879
CUSIP: 03152W109
Currency: USD
Full Time Employees: 499
Phone: 609 662 2000
Website: https://amicusrx.com
Fiscal Year End: December
IPO Date: May 31, 2007
Description:

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Address:

47 Hulfish Street, Princeton, NJ, United States, 08542

Directors & Officers

▼
Name Title Year Born
Mr. Bradley L. Campbell M.B.A. CEO, President & Director 1976
Mr. Simon Nicolas Reade Harford Chief Financial Officer 1960
Ms. Ellen S. Rosenberg J.D. Chief Legal Officer & Corporate Secretary 1963
Mr. David M. Clark Chief People Officer 1975
Dr. Jeffrey P. Castelli Ph.D. Chief Development Officer 1972
Ms. Samantha L. Prout Chief Accounting Officer & Controller 1978
Dr. Jill Weimer Ph.D. Chief Science Officer NA
Mr. Andrew Faughnan Vice President of Investor Relations NA
Mr. Patrik S. Florencio Esq. Global Chief Compliance & Risk Officer NA
Mr. Brendan McEvoy Executive Director of External Communications NA

Shares Statistics

▼
Shares Outstanding: 309.30M
Shares Float: 305.84M
% Insiders: 57.40%
% Institutions: 10,277.10%
Short % Float: 6.39%

Valuation Metrics

▼
Enterprise Value: $4.60B
Trailing P/E: 0.00
Forward P/E: 30.49

Financial Highlights

▼
Market Cap: $4.42B
EBITDA: $42.12M
PEG Ratio: $-0.18
Book Value: $0.75
Earnings/Share: $-0.04
Profit Margin: -2.35%
Operating Margin: 20.27%
ROA (TTM): 2.61%
ROE (TTM): -6.87%
Revenue (TTM): $598.70M
Revenue/Share (TTM): $1.95
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 19.50%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Mar 31, 2026 0.00 0.03 N/A -10,000.00%
Dec 31, 2025 0.00 0.07 N/A -10,000.00%
Sep 30, 2025 0.06 0.03 N/A 10,000.00%
Jun 30, 2025 -0.08 -0.11 N/A 2,727.27%
Mar 31, 2025 0.03 -0.07 N/A 14,285.71%
Dec 31, 2024 0.09 0.09 N/A -120.75%
Sep 30, 2024 -0.02 -0.01 N/A -10,000.00%
Jun 30, 2024 -0.05 -0.06 N/A 1,666.67%
Mar 31, 2024 -0.16 -0.07 N/A -12,857.14%
Dec 31, 2023 -0.11 -0.06 N/A -8,333.33%
Sep 30, 2023 -0.07 -0.08 N/A 1,250.00%
Jun 30, 2023 -0.15 -0.12 N/A -2,500.00%
Mar 31, 2023 -0.18 -0.15 N/A -2,000.00%
Dec 31, 2022 -0.19 -0.13 N/A -4,615.38%
Sep 30, 2022 -0.12 -0.19 N/A 3,684.21%
Jun 30, 2022 -0.21 -0.22 N/A 454.55%
Mar 31, 2022 -0.30 -0.25 N/A -2,000.00%
Dec 31, 2021 -0.29 -0.16 N/A -8,125.00%
Sep 30, 2021 -0.19 -0.17 N/A -1,176.47%
Jun 30, 2021 -0.19 -0.21 N/A 952.38%
Mar 31, 2021 -0.25 -0.23 N/A -869.57%
Dec 31, 2020 -0.27 -0.22 N/A -2,272.73%
Sep 30, 2020 -0.23 -0.22 N/A -454.55%
Jun 30, 2020 -0.20 -0.26 N/A 2,307.69%
Mar 31, 2020 -0.34 -0.28 N/A -2,142.86%
Dec 31, 2019 -0.35 -0.27 N/A -2,962.96%
Sep 30, 2019 -0.24 -0.32 N/A 2,500.00%
Jun 30, 2019 -0.36 -0.33 N/A -909.09%
Mar 31, 2019 -0.39 -0.31 N/A -2,580.65%
Dec 31, 2018 -0.41 -0.28 N/A -4,642.86%
Sep 30, 2018 -0.31 -0.28 N/A -1,071.43%
Jun 30, 2018 -0.33 -0.33 N/A 0.00%
Mar 31, 2018 -0.28 -0.36 N/A 2,222.22%
Dec 31, 2017 -0.41 -0.30 N/A -3,666.67%
Sep 30, 2017 -0.41 -0.31 N/A -3,225.81%
Jun 30, 2017 -0.34 -0.36 N/A 555.56%
Mar 31, 2017 -0.39 -0.36 N/A -833.33%
Dec 31, 2016 -0.42 -0.33 N/A -2,727.27%
Sep 30, 2016 -0.33 -0.31 N/A -645.16%
Jun 30, 2016 -0.40 -0.33 N/A -2,121.21%
Mar 31, 2016 -0.35 -0.34 N/A -294.12%
Dec 31, 2015 -0.36 -0.30 N/A -2,000.00%
Sep 30, 2015 -0.32 -0.25 N/A -2,800.00%
Jun 30, 2015 -0.26 -0.24 N/A -833.33%
Mar 31, 2015 -0.25 -0.20 N/A -2,500.00%
Dec 31, 2014 -0.24 -0.18 N/A -3,333.33%
Sep 30, 2014 -0.22 -0.21 N/A -476.19%
Jun 30, 2014 -0.22 -0.23 N/A 434.78%
Mar 31, 2014 -0.25 -0.24 N/A -416.67%
Dec 31, 2013 -0.18 -0.32 N/A 4,375.00%
Sep 30, 2013 -0.29 -0.34 N/A 1,470.59%
Jun 30, 2013 -0.31 -0.35 N/A 1,142.86%
Mar 31, 2013 -0.35 -0.33 N/A -606.06%
Dec 31, 2012 -0.20 -0.37 N/A 4,594.59%
Sep 30, 2012 -0.34 -0.24 N/A -4,166.67%
Jun 30, 2012 -0.20 -0.23 N/A 1,304.35%
Mar 31, 2012 -0.35 -0.35 N/A 0.00%
Dec 31, 2011 -0.25 -0.37 N/A 3,243.24%
Sep 30, 2011 -0.28 -0.33 N/A 1,515.15%
Jun 30, 2011 -0.37 -0.32 N/A -1,562.50%
Mar 31, 2011 -0.39 -0.35 N/A -1,142.86%
Dec 31, 2010 -0.48 -0.15 N/A -22,000.00%
Sep 30, 2010 -0.56 -0.49 N/A -1,428.57%
Jun 30, 2010 -0.41 -0.53 N/A 2,264.15%
Mar 31, 2010 -0.54 -0.58 N/A 689.66%
Dec 31, 2009 1.45 -0.59 N/A 34,576.27%
Sep 30, 2009 -0.59 -0.68 N/A 1,323.53%
Jun 30, 2009 -0.60 -0.65 N/A 769.23%
Mar 31, 2009 -0.55 -0.64 N/A 1,406.25%
Dec 31, 2008 -0.63 -0.62 N/A -161.29%
Sep 30, 2008 -0.36 -0.47 N/A 2,340.43%
Jun 30, 2008 -0.41 -0.51 N/A 1,960.78%
Mar 31, 2008 -0.34 -0.38 N/A 1,052.63%
Dec 31, 2007 -0.53 -0.40 N/A -3,250.00%
Sep 30, 2007 -0.46 -0.46 N/A 0.00%
Jun 30, 2007 -1.37 -0.48 N/A -18,541.67%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $213.75M $N/A $785.03M $590.99M $194.05M
2023-12-31 $246.99M $N/A $777.88M $617.71M $160.17M
2022-12-31 $148.81M $N/A $724.17M $601.12M $123.05M
2021-12-31 $245.20M $N/A $905.14M $597.77M $307.37M
2020-12-31 $163.24M $N/A $886.52M $600.14M $286.38M
2019-12-31 $142.84M $N/A $850.21M $373.78M $476.43M
2018-12-31 $79.75M $N/A $789.95M $447.04M $342.91M
2017-12-31 $49.06M $N/A $627.02M $274.17M $352.85M
2016-12-31 $187.03M $N/A $1.04B $676.69M $360.15M
2015-12-31 $69.49M $N/A $908.38M $560.55M $347.83M
2014-12-31 $24.07M $N/A $209.97M $87.79M $122.18M
2013-12-31 $43.64M $N/A $127.56M $81.81M $45.75M
2012-12-31 $33.97M $N/A $110.09M $40.87M $69.22M
2011-12-31 $25.67M $N/A $69.80M $40.20M $29.59M
2010-12-31 $29.57M $N/A $112.55M $47.62M $64.93M
2009-12-31 $19.34M $N/A $85.37M $13.54M $71.83M
2008-12-31 $28.07M $N/A $128.77M $57.73M $71.04M
2007-12-31 $44.19M $N/A $167.10M $63.80M $103.30M
2006-12-31 $12.13M $N/A $59.65M $137.16M $-77.52M
2005-12-31 $6.45M $N/A $28.67M $64.50M $-35.83M
2004-12-31 $257.00K $N/A $5.07M $922.00K $4.15M
2003-12-31 $N/A $N/A $501.00K $5.78M $-5.28M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 19, 2025 N/A N/A N/A N/A N/A N/A
Dec 02, 2024 N/A N/A N/A N/A N/A N/A
Nov 06, 2024 N/A N/A N/A N/A N/A N/A
Nov 01, 2024 N/A N/A N/A N/A N/A N/A
Oct 01, 2024 N/A N/A N/A N/A N/A N/A
Sep 03, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist